You have no items in your cart.
Angion Biomedica Cleared for Phase 1B Trial of ANG-3070 in IPF
Pulmonary Fibrosis News
The U.S. Food and Drug Administration (FDA) has given permission for Angion Biomedica to launch a Phase clinical 1b trial to test its experimental anti-fibrotic medication ANG-3070 in people with ... Read more